000 01421 a2200385 4500
005 20250515211207.0
264 0 _c20100603
008 201006s 0 0 eng d
022 _a1744-7593
024 7 _a10.1517/17425240903544462
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aShowalter, Shayna L
245 0 0 _aIdentifying pancreatic cancer patients for targeted treatment: the challenges and limitations of the current selection process and vision for the future.
_h[electronic resource]
260 _bExpert opinion on drug delivery
_cMar 2010
300 _a273-84 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aDrug Delivery Systems
650 0 4 _aFrameshift Mutation
650 0 4 _aHumans
650 0 4 _aPancreatic Neoplasms
_xdrug therapy
650 0 4 _aPatient Selection
700 1 _aCharles, Sarah
700 1 _aBelin, Justin
700 1 _aCozzitorto, Joseph
700 1 _aEinstein, Peter
700 1 _aRichards, Nathan G
700 1 _aSauter, Patricia K
700 1 _aKennedy, Eugene P
700 1 _aWitkiewicz, Agnes
700 1 _aBrody, Jonathan R
700 1 _aYeo, Charles J
773 0 _tExpert opinion on drug delivery
_gvol. 7
_gno. 3
_gp. 273-84
856 4 0 _uhttps://doi.org/10.1517/17425240903544462
_zAvailable from publisher's website
999 _c19569226
_d19569226